Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

PACS (PACS) EBITDA Margin: 2023-2025

Historic EBITDA Margin for PACS (PACS) over the last 3 years, with Q3 2025 value amounting to 6.42%.

  • PACS's EBITDA Margin rose 41800.0% to 6.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.63%, marking a year-over-year increase of 22600.0%. This contributed to the annual value of 3.01% for FY2024, which is 36700.0% down from last year.
  • Latest data reveals that PACS reported EBITDA Margin of 6.42% as of Q3 2025, which was up 41800.0% from 3.89% recorded in Q2 2025.
  • In the past 5 years, PACS's EBITDA Margin ranged from a high of 7.33% in Q4 2023 and a low of 3.43% during Q2 2024
  • Its 3-year average for EBITDA Margin is 3.84%, with a median of 4.25% in 2023.
  • Its EBITDA Margin has fluctuated over the past 5 years, first tumbled by -23800bps in 2024, then surged by 73200bps in 2025.
  • Quarter analysis of 3 years shows PACS's EBITDA Margin stood at 7.33% in 2023, then fell by -19bps to 5.96% in 2024, then grew by 8bps to 6.42% in 2025.
  • Its last three reported values are 6.42% in Q3 2025, 3.89% for Q2 2025, and 2.23% during Q1 2025.